Lexacalcitol

N/A

Report date: 2022/05/25 11:16:45

Base Information

Drug NameLexacalcitol
Drug Alias Name来沙骨化醇KH-1060KH-106
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionVitamin D receptor agonistsImmunosuppressants
TargetsVitamin D receptor
Therapy Area/IndicationsRejection of pancreatic transplantationRejection of renal transplantationAutoimmune Diseases +[6] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesLeo Pharma Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesLeo Pharma Inc
Active IndicationsN/A
Inactive IndicationsRejection of pancreatic transplantationRejection of renal transplantationAutoimmune Diseases +[6] 

Other Information

ATC CodeN/A
Related LinksN/A